|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007784,
umls-concept:C0030705,
umls-concept:C0036525,
umls-concept:C0148199,
umls-concept:C0220650,
umls-concept:C0332293,
umls-concept:C0376249,
umls-concept:C0599894,
umls-concept:C1268567,
umls-concept:C1378703,
umls-concept:C1522484,
umls-concept:C2757011
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-12-24
|
|
pubmed:abstractText |
To report the high incidence of intracerebral hemorrhage (ICH) in patients with metastatic renal cell carcinoma (RCC) treated with the tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptor (VEGFR).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0302-2838
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
376-81
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17825982-Adult,
pubmed-meshheading:17825982-Aged,
pubmed-meshheading:17825982-Benzenesulfonates,
pubmed-meshheading:17825982-Brain Neoplasms,
pubmed-meshheading:17825982-Carcinoma, Renal Cell,
pubmed-meshheading:17825982-Cerebral Hemorrhage,
pubmed-meshheading:17825982-Female,
pubmed-meshheading:17825982-Humans,
pubmed-meshheading:17825982-Indoles,
pubmed-meshheading:17825982-Kidney Neoplasms,
pubmed-meshheading:17825982-Male,
pubmed-meshheading:17825982-Middle Aged,
pubmed-meshheading:17825982-Protein Kinase Inhibitors,
pubmed-meshheading:17825982-Pyridines,
pubmed-meshheading:17825982-Pyrroles,
pubmed-meshheading:17825982-Receptors, Vascular Endothelial Growth Factor
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
High frequency of intracerebral hemorrhage in metastatic renal carcinoma patients with brain metastases treated with tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptor.
|
|
pubmed:affiliation |
Department of Medical Oncology, C.R.L.C. Val d'Aurelle, Montpellier, France.
|
|
pubmed:publicationType |
Journal Article
|
